Evidence map›Paper›PMID 40732021›Full record

ArticleMicroorganisms2025

Cytomegalovirus Infection Screening in Pregnant Women from Northwest Romania: Results of a 15-Year Follow-Up Program.

Monica Muntean, Violeta Tincuța Briciu, Angela Monica Ionică, Melinda Horvat, Mihaela Lupse, Amanda Radulescu

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Monica MunteanInfectious Diseases and Epidemiology Department, "Iuliu Hațieganu " University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-1288-3918
Violeta Tincuța BriciuInfectious Diseases and Epidemiology Department, "Iuliu Hațieganu " University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Angela Monica IonicăClinical Hospital of Infectious Diseases, 400348 Cluj-Napoca, Romania.ORCID 0000-0002-1438-2498
Melinda HorvatInfectious Diseases and Epidemiology Department, "Iuliu Hațieganu " University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Mihaela LupseInfectious Diseases and Epidemiology Department, "Iuliu Hațieganu " University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID 0000-0003-4010-2901
Amanda RadulescuInfectious Diseases and Epidemiology Department, "Iuliu Hațieganu " University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-4154-0498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy-related cytomegalovirus (CMV) infection may have negative consequences on the developing fetus and child. In Romania, screening for CMV infection is included in the first prenatal evaluation. We aimed to evaluate the seroprevalence rates in pregnant women who underwent screening over 15 years (May 2008-February 2023). We evaluated 28,012 pregnant women, from whom 23,970 (85.57%) had an index CMV screening, and 4082 had at least two presentations during the same or consecutive pregnancies. A total of 32,290 paired anti-CMV IgM/IgG serological tests were performed. Passed infection with IgG positivity represented 90.15% (29,110) of all tests, corresponding to 28,649 women (88.72%). The seroprevalence increased with women's age, was more frequently associated with rural residence, and decreased in time intervals. A total of 2322 women (9.69%) displaying an IgM/IgG negative pattern were at risk of acquiring the infection during pregnancy. Only 144 out of 2342 (6.14%) women at risk presented twice during the same pregnancy, of which 12 women (0.51%) displayed a pattern of primary infection. Our population from Northwest Romania shows a high rate of immunization against CMV infection and a low risk of primary infection. We found a low adherence to retesting in cases of probable primary CMV infections, which highlights the need for infection mitigation by hygiene measures and improvement of the existing protocols.

Indexed as

anti-cytomegalovirus antibodiesCytomegalovirusprenatal screeningprimary infection

Identifiers

PMID40732021
PMCPMC12299134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.